Tin tức & Cập nhật

A large study from Denmark presented at EASD 2025 suggests that overweight and obesity may protect against death.

Implementation of physician-led medication reviews through interdisciplinary dialogue can reduce the number of prescribed drugs and potentially inappropriate prescriptions (PIPs) in psychiatric outpatients with coexisting diabetes, a study has shown.

The 2-year outcomes from the phase II BANDIT* trial confirm the potential of the Janus kinase (JAK) inhibitor baricitinib for the treatment of new-onset type 1 diabetes (T1D).

Smoking, obesity, treatment duration, and pre-existing cardiac diseases may contribute to the development of cardiotoxicity among patients with cancer who are undergoing 5-fluorouracil (5-FU) chemotherapy, suggests a recent study.

Treatment with semaglutide and dulaglutide results in a significantly lower risk of adverse cognitive decline in patients with heart failure (HF), as shown by the results of a retrospective cohort study using real-world data.